HIGHLIGHTS
- who: Thioredoxin Reductase Inhibitors as and collaborators from the Research Institute for Medicines (iMedULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Department University of Patras, Greece have published the Article: Thioredoxin Reductase Inhibitors as Potential Antitumors: Mercury Compounds Ef fi cacy in Glioma Cells, in the Journal: (JOURNAL)
- what: This study evaluated the effect of TmHg and EtHg on the viability of GL261 cells, assessing the effects on the thioredoxin system, mitochondrial redox function, ROS production, and apoptosis.
SUMMARY
Glioblastoma multiforme (GBM) is the most aggressive and common form of glioma . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.